The DOI matches its Crossref record; 154 of the 156 references it cites were found in a registry or an index.
Sarcopenia: revised European consensus on definition and diagnosis
Open accessAbstract
Background: in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives: to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations: sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions: EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These variables are critical indicators of mobility, independence, and fall risk in older adults [3].”
From Efficacy of Power Training on Sarcopenic Obesity in Community-Dwelling Older Women: A 32-Week Randomized Clinical Trial (2025) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These individuals—and especially women and those with T2D, prediabetes, or metabolic dysfunction‐associated steatotic liver disease (MASLD)—are already at high risk of sarcopenia (age‐related loss of skeletal muscle function and mass), 30 , 31 sarcopenic obesity (the co‐existence of excess adiposity and low muscle mass/function, which can occur at any age 32 ), and the serious negative health out”
From Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity (2025) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sarcopenia definitions have evolved through European and Asian consensus updates that place greater emphasis on muscle strength and physical performance, while the ESPEN and EASO consensus and the Sarcopenic Obesity Global Leadership Initiative have attempted to standardize SO diagnosis and research priorities (2, 7–9).”
From Exercise-based interventions for sarcopenic obesity in middle-aged and older adults: an umbrella review of systematic reviews with pairwise meta-analyses and network meta-analyses (2026) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, a major reason for the variation in sarcopenic obesity prevalence is the method of adjusting muscle quantity for body size.46,47,55,57”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All regional working groups on the definition of sarcopenia have moved from recommending using lean mass alone to adding muscle strength and function, and switching the focus of the definition from lean mass to muscle strength and function.[46][47][48]”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [46]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“The updated definition of sarcopenia elevated low muscle strength to the forefront as a primary indicator of sarcopenia and identified poor physical performance as indicative of severe sarcopenia (52).”
From Evolution of the diagnosis of malnutrition in adults: a primer for clinicians (2024) · cites this paper as [52]
In the citing paper
“In this revised consensus, low physical performance is proposed as an indicator of severe sarcopenia.”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [19]
In the citing paper
“Notably, the EWGSOP2 reported low muscle strength as a key characteristic of sarcopenia to facilitate the prompt identification of sarcopenia in practice (19).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [19]
In the citing paper
“the updated EWGSOP2 guidelines that focused on low muscle strength using grip strength as a central factor for diagnosing sarcopenia, as muscle strength has been shown to better predict poor outcomes than muscle mass in sarcopenia (3–5).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [3]
In the citing paper
“Therefore, the adverse effects of sarcopenia on quality of life, health care demand, morbidity, and mortality can affect both middle‐aged and older‐aged adults. 1 , 2 , 6”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“but the decline in muscle mass starts from ~40 years onwards. 1”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“Sarcopenia is a progressive and complex disease associated with a higher burden of morbidity and mortality. 1 , 2 , 6”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“The revised EWGSOP2 emphasizes that severe sarcopenia should be based on the combination of sarcopenia plus a low physical performance, such as slow gait speed. 1”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“Nowadays, it is known that the decrease in muscle mass function and quality start at ~40 years and that sarcopenia often appears earlier in life. 1 , 2”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“the biggest impact is likely to be on prevalence estimated using EWGSWOP2 1 as well as the AWGS that updated its sarcopenia definition and its cut‐off points in March 2020. 33”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“although the effect of obesity on years-of-life-lost is greatest in younger adults, and the magnitude of years lost with obesity decreases with ageing [16], irrespective of sex, smoking status, physical activity level, or socioeconomic status [35]”
From Obesity pharmacotherapy in older adults: a narrative review of evidence (2025) · cites this paper as [35]
In the citing paper
“Sarcopenia, defined as low skeletal muscle mass and function, has been identified and described as a geriatric syndrome with a multifactorial aetiology whose prevalence increases with age [3-5].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [5]
In the citing paper
“This definition was revised in 2019 to describe sarcopenia as “a muscle disease originating from adverse muscle changes that accumulate over a lifetime”.”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“The recent guidelines from EWGSOP have made slight modifications to previous diagnostic cutoff values, proposing an ALMI < 5.5 kg/m2 in women and ALMI < 7.0 kg/m2 in men be used as criteria for defining low muscle mass (1).”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“EWGSOP proposes a screening and diagnostic approach for sarcopenia termed “Find-Assess-Confirm-Severity” (F-A-C-S; Figure 1).1”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“Among the strategies for preserving muscle quantity and quality, resistance exercise training is a reliable approach.1”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“This is of particular concern in older adults, where muscle loss contributes to frailty, impaired glucose regulation, increased fall risk, and decreased quality of life [33].”
From Unintended Consequences of Obesity Pharmacotherapy: A Nutritional Approach to Ensuring Better Patient Outcomes (2025) · cites this paper as [33]
In the citing paper
“fatigue and grip strength are also well-established measures of sarcopenia and physical frailty54,55 and are commonly used to assess the pathological impairment of quality of life in older people in clinical practice.”
From Trigonelline Is an NAD+ Precursor That Improves Muscle Function during Ageing and Is Reduced in Human Sarcopenia (2024) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418 · cited 1×
“For the TUG test, individuals are asked to rise from a standard chair, walk to a marker 3 m away, turn around, walk back and sit down again [89].”
MethodSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Self-citationClegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503
A global clinical measure of fitness and frailty in elderly people
Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I. G., Bruera, E. D., Fainsinger, R. L., Jatoi, A., Loprinzi, C. L., Macdonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 6,020
Gait speed and survival in older adults.
Studenski, S. (2011) · JAMA · doi:10.1001/jama.2010.1923 · Cited by 4,558 · cited 1×
“…<7.0 kg/m2 <6.0 kg/m2 Gould (2014) [125] EWGSOP2 sarcopenia cut-off points for low performance Gait speed ≤0.8 m/s Cruz-Jentoft (2010) [1] Studenski (2011) [84] SPPB ≤8 point score Pavasini (2016) [90] Guralnik (1995) [126] TUG ≥20 s Bischoff (2003) [127] 400 m walk test Non-completion…”
BackgroundInfluentialFrailty Consensus: A Call to Action
Morley, J. E., Vellas, B. J., van Kan, G. A., Anker, S. D., Bauer, J. M., Bernabei, R., Cesari, M., Chumlea, W. C., Doehner, W., Evans, J., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.03.022 · Cited by 4,201
Self-citationLower-extremity function in persons over the age of 70 years as a predictor of subsequent disability
Guralnik, J. M., Ferrucci, L., Simonsick, E. M., Salive, M. E., & Wallace, R. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320902 · Cited by 4,083
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
Flagged first, then by citations
2 of the 156 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Keller, 2018, Sarcopenia, Wien Med Wochenschr
Cited by
Sorted by citations
Items 701–800 of 1,118
Luna, N. M., Orea‐Tejeda, A., González‐Islas, D., Flores-Cisneros, L. A., Keirns‐Davis, C., Sánchez‐Santillán, R., García, I. P., Ayala, Y. R. G., Martínez-Vázquez, V., & Reyna, Ó. U. M. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01907-1 · Cited by 66
Yi, Y., Baek, J. Y., Lee, E., Jung, H., & Jang, I. (2022) · Life · doi:10.3390/life12070994 · Cited by 72
Strength training in elderly: An useful tool against sarcopenia
Cannataro, R., Cione, E., Bonilla, D. A., Cerullo, G., Angelini, F., & D’Antona, G. (2022) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2022.950949 · Cited by 66
Cancello, R., Brunani, A., Brenna, E., Soranna, D., Bertoli, S., Zambon, A., Lukaski, H. C., & Capodaglio, P. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09774-1 · Cited by 71
Is dexamethasone-induced muscle atrophy an alternative model for naturally aged sarcopenia model?
Wang, B. Y., Hsiao, A. W., Wong, N., Chen, Y., Lee, C., & Lee, W. (2022) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2022.11.005 · Cited by 71
Insights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review
Mellem, R. H., Girotto, O. S., Marques, E. B., Laurindo, L. F., Grippa, P. C., Mendes, C. G., Garcia, L. N. H., Bechara, M. D., Barbalho, S. M., Sinatora, R. V., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11010136 · Cited by 73
C‐terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review
Monti, E., Sarto, F., Sartori, R., Zanchettin, G., Löfler, S., Kern, H., Narici, M. V., & Zampieri, S. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13189 · Cited by 66
Mo, Y., Zhou, Y., Chan, H. Y. L., Evans, C., & Maddocks, M. M. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04489-7 · Cited by 80
Neuromuscular impairment at different stages of human sarcopenia
Sarto, F., Franchi, M. V., McPhee, J. S., Stashuk, D. W., Paganini, M., Monti, E., Rossi, M., Sirago, G., Zampieri, S., Motanova, E. S., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13531 · Cited by 67
“Sarcopenia, the progressive loss of skeletal muscle mass and function with ageing, 1,2 is recognized as a clinical disorder that affects individuals ’ quality of life and leads to an increased risk of falls, functional decline, frailty and mortality.”
BackgroundMethodInfluentialEmerging Targets and Treatments for Sarcopenia: A Narrative Review
Cacciatore, S., Calvani, R., Esposito, I., Massaro, C., Gava, G., Picca, A., Tosato, M., Marzetti, E., & Landi, F. (2024) · Nutrients · doi:10.3390/nu16193271 · Cited by 75
“Sarcopenia is a progressive and generalized skeletal muscle disease characterized by accelerated loss of muscle mass, strength, and physical function [1].”
BackgroundSelf-citationMyosteatosis: diagnostic significance and assessment by imaging approaches
García-Díez, A. I., Porta-Vilaró, M., Isern-Kebschull, J., Naude, N., Guggenberger, R., Brugnara, L., Milinkovic, A., Bartolomé-Solanas, Á., Soler-Perromat, J. C., Amo, M. D., et al. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-24-365 · Cited by 67
Damanti, S., Azzolino, D., Roncaglione, C., Arosio, B., Rossi, P. D., & Cesari, M. (2019) · Nutrients · doi:10.3390/nu11091991 · Cited by 72
Self-citationIf my muscle could talk: Myokines as a biomarker of frailty
Coelho‐Júnior, H. J., Picca, A., Calvani, R., Uchida, M. C., & Marzetti, E. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110715 · Cited by 71
Comparing SARC-F with SARC-CalF for screening sarcopenia in advanced cancer patients
Fu, X., Tian, Z., Thapa, S., Sun, H., Wen, S., Xiong, H., & Yu, S. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.02.020 · Cited by 72
Effects of enriched branched-chain amino acid supplementation on sarcopenia
Ko, C.-H., Wu, S., Wang, S., Chang, Y., Chang, C., Kuan, T., Chuang, H.-Y., Chang, C., Chou, W., & Wu, C. (2020) · Aging · doi:10.18632/aging.103576 · Cited by 70
Petermann-Rocha, F. E., Gray, S. R., Pell, J. P., Ho, F. K. W., & Celis-Morales, C. A. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.044 · Cited by 65
Relationship between smoking and the incidence of sarcopenia: The SarcoPhAge cohort
Locquet, M., Bruyère, O., Lengelé, L., Reginster, J., & Beaudart, C. (2021) · Public Health · doi:10.1016/j.puhe.2021.01.017 · Cited by 72
Self-citationPadilla, C. J., Harrigan, M. E., Harris, H. N., Schwab, J. M., Rutkove, S. B., Rich, M. M., Clark, B. C., & Arnold, W. D. (2021) · GeroScience · doi:10.1007/s11357-021-00369-3 · Cited by 63
Bioelectrical impedance (BIA)-derived phase angle in adults with obesity: A systematic review
Vincenzo, O. D., Marra, M., Sacco, A. M., Pasanisi, F., & Scalfi, L. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.07.035 · Cited by 69
Wang, Z., Xu, X., Gao, S., Wu, C., Song, Q., Shi, Z., Su, J., & Zang, J. (2022) · Nutrients · doi:10.3390/nu14122458 · Cited by 66
Exercise and physical performance in older adults with sarcopenic obesity: A systematic review
Ghiotto, L., Muollo, V., Tatangelo, T., Schena, F. F., & Rossi, A. P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.913953 · Cited by 74
Paez, H. G., Pitzer, C. R., & Alway, S. E. (2023) · Cells · doi:10.3390/cells12020249 · Cited by 71
Bernhardt, A. M. J., Copeland, H., Deswal, A., Gluck, J., Givertz, M. M., Bernhardt, A. M. J., Gluck, J., Garan, A. R., Hall, S. A., Hayanga, A. J., et al. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2022.11.003 · Cited by 68
An Integrated Approach to Skeletal Muscle Health in Aging
Agostini, D., Gervasi, M., Ferrini, F., Bartolacci, A., Stranieri, A., Piccoli, G., Barbieri, E., Sestili, P., Patti, A., Stocchi, V., et al. (2023) · Nutrients · doi:10.3390/nu15081802 · Cited by 81
Hosoda, R., Nakashima, R., Yano, M., Iwahara, N., Asakura, S., Nojima, I., Saga, Y., Kunimoto, R., Horio, Y., & Kuno, A. (2023) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2023.04.001 · Cited by 77
The Role of the Kynurenine Pathway in the Pathophysiology of Frailty, Sarcopenia, and Osteoporosis
Ballesteros, J., Rivas, D., & Duque, G. (2023) · Nutrients · doi:10.3390/nu15143132 · Cited by 63
Management of Coronary Artery Disease in Older Adults: Recent Advances and Gaps in Evidence
Cacciatore, S., Spadafora, L., Bernardi, M., Galli, M., Betti, M., Perone, F., Nicolaio, G., Marzetti, E., Martone, A. M., Landi, F., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165233 · Cited by 73
Self-citationTo Be Frail or Not to Be Frail: This Is the Question—A Critical Narrative Review of Frailty
Sciacchitano, S., Carola, V., Nicolais, G., Sciacchitano, S., Napoli, C., Mancini, R., Rocco, M., & Coluzzi, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030721 · Cited by 74
Vezzoli, A., Mrakic‐Sposta, S., Montorsi, M., Porcelli, S., Vago, P., Cereda, F., Longo, S., Maggio, M. G., & Narici, M. V. (2019) · Antioxidants · doi:10.3390/antiox8100431 · Cited by 66
Self-citationIannone, F., Montesanto, A., Cione, E., Crocco, P., Caroleo, M. C., Dato, S., Rose, G., & Passarino, G. (2020) · Nutrients · doi:10.3390/nu12020297 · Cited by 65
Critical evaluation of different available guidelines for late‐onset hypogonadism
Giagulli, V., Castellana, M., Lisco, G., & Triggiani, V. (2020) · Andrology · doi:10.1111/andr.12850 · Cited by 54
Leitfaden Ernährungstherapie in Klinik und Praxis (LEKuP)
Hauner, H., Beyer-Reiners, E., Bischoff, G., Breidenassel, C., Ferschke, M., Gebhardt, A., Holzapfel, C., Lambeck, A., Meteling-Eeken, M., Paul, C., et al. (2019) · Aktuelle Ernährungsmedizin · doi:10.1055/a-1030-5207 · Cited by 64
Dodds, R. M., Murray, J. C., Robinson, S. M., & Sayer, A. A. (2020) · European Geriatric Medicine · doi:10.1007/s41999-020-00310-5 · Cited by 64
Self-citationMuscle loss contributes to higher morbidity and mortality in COPD : An analysis of national trends
Attaway, A. H., Welch, N., Hatipoglu, U. S., Zein, J., & Dasarathy, S. (2020) · Respirology · doi:10.1111/resp.13877 · Cited by 68
Kang, S., Moon, M. K., Kim, W. K., & Koo, B. K. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12598 · Cited by 65
Fu, X., Tian, Z., Wen, S., Sun, H., Thapa, S., Xiong, H., Liu, H., Li, L., & Yu, S. (2020) · Nutrition · doi:10.1016/j.nut.2020.111032 · Cited by 64
Kim, J., Yoon, J. S., Kim, E. J., Hong, H., Kwon, H. H., Jung, C. Y., Kim, K. C., Sung, Y. S., Park, S., Kim, S., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab085 · Cited by 64
Socioeconomic Inequality and Risk of Sarcopenia in Community-Dwelling Older Adults
Swan, L., Warters, A., & OʼSullivan, M. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s310774 · Cited by 64
Nowak, S., Theis, M., Wichtmann, B. D., Faron, A., Froelich, M. F., Tollens, F., Geißler, H. L., Block, W., Luetkens, J. A., Attenberger, U. I., et al. (2021) · European Radiology · doi:10.1007/s00330-021-08313-x · Cited by 68
Could very low-calorie ketogenic diets turn off low grade inflammation in obesity? Emerging evidence
Barrea, L., Caprio, M., Watanabe, M., Cammarata, G., Feraco, A., Muscogiuri, G., Verde, L., Colao, A., & Savastano, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2054935 · Cited by 66
Liver transplantation in the patient with physical frailty
Tandon, P., Zanetto, A., Piano, S. S., Heimbach, J. K., & Dasarathy, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.025 · Cited by 64
Kidney function in cachexia and sarcopenia: Facts and numbers
Okamura, M., Konishi, M., Butler, J., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13260 · Cited by 64
“On the other hand, sarcopenia is defined as a loss of muscle mass and strength, which can be divided into ‘primary sarcopenia’ due to aging and ‘secondary sarcopenia’ due to one or more obvious causes such as reduced activity, chronic disease, or poor nutritional status.(2) The diagnostic criteria for sarcopenia inclu…”
BackgroundEly, I. A., Phillips, B. E., Smith, K., Wilkinson, D. J., Piasecki, M., Breen, L., Larsen, M. S., & Atherton, P. J. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.08.010 · Cited by 64
Gustafsson, T. P., & Ulfhake, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010932 · Cited by 78
“…(definition guidelines for diagnostic criteria have been published and revised by European, Asian and North American working groups (the EWGSOP2 [30], the Asian Working Group for Sarcopenia (AWGS) [31], and the FNIH [32]), a condition that becomes clinically significant in the sixth decade of…”
BackgroundSánchez‐Rodríguez, D., Marco, E., Dávalos‐Yerovi, V., et al. (2019) · The journal of nutrition health & aging · doi:10.1007/s12603-019-1204-z · Cited by 64
Self-citationMultiple Modes of Vitamin K Actions in Aging-Related Musculoskeletal Disorders
Azuma, K., & Inoue, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112844 · Cited by 64
Lindqvist, C., Slinde, F., Majeed, A., Bottai, M., & Wåhlin, S. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.07.024 · Cited by 64
Looijaard, S. M. L. M., Hekkert, M. L. T. L., Wüst, R. C. I., Otten, R. H. J., Meskers, C. G. M., & Maier, A. B. (2020) · Acta Physiologica · doi:10.1111/apha.13516 · Cited by 69
Optimizing Adult Protein Intake During Catabolic Health Conditions
Phillips, S. M., Paddon-Jones, D., & Layman, D. K. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa047 · Cited by 65
Effect of sarcopenic obesity on deterioration of physical function in the elderly
Kong, H. H., Won, C. W., & Kim, W. D. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104065 · Cited by 63
Makizako, H., Nakai, Y., Tomioka, K., Taniguchi, Y., Sato, N., Wada, A., Kiyama, R., Tsutsumimoto, K., Ohishi, M., Kiuchi, Y., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051386 · Cited by 73
Shafiee, G., Heshmat, R., Ostovar, A., Khatami, F., Fahimfar, N., Arzaghi, S. M., Gharibzadeh, S., Hanaei, S., Nabipour, I., & Larijani, B. A. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00553-w · Cited by 65
Ultrasound imaging, a stethoscope for body composition assessment
Ponti, F., Cinque, A. D., Fazio, N., Napoli, A., Guglielmi, G., & Bazzocchi, A. (2020) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-19-1048 · Cited by 63
Osteosarcopenia: beyond age-related muscle and bone loss
Belchior, G. F., Kirk, B., da Silva, E. A. P., & Duque, G. (2020) · European Geriatric Medicine · doi:10.1007/s41999-020-00355-6 · Cited by 69
Vitale, J. A., Bonato, M., Borghi, S., Messina, C., Albano, D., Corbetta, S., Sconfienza, L. M., & Banfi, G. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17249533 · Cited by 67
Petermann-Rocha, F., Pell, J., Celis-Morales, C., & Ho, F. (2021) · Journal of public health · doi:10.1093/pubmed/fdaa226 · Cited by 52
Skeletal muscle and childhood cancer: Where are we now and where we go from here
Goodenough, C. G., Partin, R. E., & Ness, K. K. (2021) · Aging and Cancer · doi:10.1002/aac2.12027 · Cited by 65
Nevill, A. M., Tomkinson, G. R., LANG, J. J., WUTZ, W., & MYERS, T. D. (2021) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002771 · Cited by 64
Characterizing Sex Differences in Physical Frailty Phenotypes in Heart Failure
Denfeld, Q. E., Habecker, B. A., Camacho, S. A., Davis, M. C., Gupta, N. C., Hiatt, S. O., Medysky, M. E., Purnell, J. Q., Winters‐Stone, K. M., & Lee, C. S. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.008076 · Cited by 63
Musculoskeletal Changes Across the Lifespan: Nutrition and the Life-Course Approach to Prevention
Azzolino, D., Spolidoro, G. C. I., Saporiti, E., Luchetti, C., Agostoni, C. V., & Cesari, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.697954 · Cited by 71
Self-citationCheng, S., Chen, K., Chen, C., Chu, W., & Kang, Y. (2021) · Nutrients · doi:10.3390/nu13103589 · Cited by 63
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
Perisetti, A., Goyal, H., Yendala, R., Chandan, S., Tharian, B., & Thandassery, R. B. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i4.432 · Cited by 65
Diabetic sarcopenia: metabolic and molecular appraisal
Giha, H. A., Alamin, O. A. O., & Sater, M. S. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01883-2 · Cited by 66
Prokopidis, K., Mazidi, M., Sankaranarayanan, R., Tajik, B., McArdle, A., & Isanejad, M. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522001787 · Cited by 65
Labata‐Lezaun, N., González-Rueda, V., Llurda-Almuzara, L., López-de–Celis, C., Rodríguez‐Sanz, J., Bosch, J., Vicente‐Rodríguez, G., Gorczakowska, D., Araluze-Arizti, P., & Pérez‐Bellmunt, A. (2022) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2022.104838 · Cited by 79
Partridge, J. S. L., Ryan, J., Dhesi, J. K., The CPOC-BGS perioperative frailty guideline group, Bailey, T., Barker, C., Bates, L., Bell, R. B., Bryden, D. C., Carter, S., et al. (2022) · Age and Ageing · doi:10.1093/ageing/afac237 · Cited by 71
Hénin, G., Loumaye, A., Leclercq, I. A., & Lanthier, N. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100963 · Cited by 73
Hou, Y., Xiang, J., Wang, B., Duan, S., Song, R., Zhou, W., Tan, S., & He, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1263650 · Cited by 72
Zhuang, C., Shen, X., Zou, H., Dong, Q., Cai, H.-Y., Chen, X.-L., Yu, Z., & Wang, S.-L. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.10.024 · Cited by 63
Johansson, J., Strand, B. H., Morseth, B., Hopstock, L. A., & Grimsgaard, S. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01860-w · Cited by 62
Thyroid Function and Sarcopenia: Results from the ELSA-Brasil Study
Szlejf, C., Suemoto, C. K., Janovsky, C. C. P. S., Barreto, S. M., Diniz, M. D. F. H. S., Lotufo, P. A., & Bensenor, I. M. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16416 · Cited by 60
Yin, Y.-H., Liu, J. Y. W., & Välimäki, M. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110937 · Cited by 61
von Berens, Å., Obling, S. R., Nydahl, M., Koochek, A., Lissner, L., Skoog, I., Frändin, K., Skoglund, E., Rothenberg, E., & Cederholm, T. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01578-9 · Cited by 62
Self-citationGadelha, A. B., Cesari, M., Corrêa, H. D. L., Neves, R. V. P., Sousa, C. V., Deus, L. A., Souza, M. K., Reis, A. L., Moraes, M. R., Prestes, J., et al. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-02799-6 · Cited by 62
Self-citationPrinciples of the activin receptor signaling pathway and its inhibition
Lodberg, A. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.04.001 · Cited by 63
Prokopidis, K., & Witard, O. C. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422421000135 · Cited by 66
Low muscle mass in older adults and mortality: A systematic review and meta-analysis
de Santana, F. M., Premaor, M. O., Tanigava, N. Y., & Pereira, R. M. R. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111461 · Cited by 66
Pratt, J., VITO, G. D., Narici, M. V., Segurado, R., Dolan, J., Conroy, J., & Boreham, C. A. (2021) · GeroScience · doi:10.1007/s11357-021-00410-5 · Cited by 69
Dommershuijsen, L. J., Ragunathan, J., Ruiter, R., Groothof, D., Mattace-Raso, F. U. S., Ikram, M. A., & Polinder‐Bos, H. A. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111646 · Cited by 63
Comparing SARC-CalF With SARC-F for Screening Sarcopenia in Adults With Type 2 Diabetes Mellitus
Xu, Z., Zhang, P., Chen, Y., Jiang, J., Zhou, Z., & Zhu, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.803924 · Cited by 63
Sinn, D. H., Kang, D., Kang, M., Güallar, E., Hong, Y. S., Lee, K. H., Park, J., Cho, J., & Gwak, G. (2022) · Hepatology · doi:10.1002/hep.32578 · Cited by 64
Lysyl oxidase‐like 2 inhibitor rescues D‐galactose‐induced skeletal muscle fibrosis
Wu, Y., Wu, Y., Yang, Y., Yu, J., Wu, J., Liao, Z., Guo, A., Sun, Y., Zhao, Y., Chen, J., et al. (2022) · Aging Cell · doi:10.1111/acel.13659 · Cited by 62
Caccialanza, R., Cotogni, P., Cereda, E., et al. (2022) · Journal of Cancer · doi:10.7150/jca.73130 · Cited by 62
Limited physician knowledge of sarcopenia: A survey
Guralnik, J. M., Cawthon, P. M., D, S. B. M., et al. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18227 · Cited by 63
Self-citationNishita, Y., Nakamura, A., Kato, T., Otsuka, R., Iwata, K., Tange, C., Ando, F., Ito, K., Shimokata, H., & Arai, H. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.09.001 · Cited by 63
Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach
Nishi, H., Takemura, K., Higashihara, T., & Inagi, R. (2020) · Nutrients · doi:10.3390/nu12061814 · Cited by 64
Song, M., Zhang, Q., Tang, M., Zhang, X., Ruan, G., Zhang, X., Zhang, K., Ge, Y., Yang, M., Li, Q., et al. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12778 · Cited by 64
Liu, H.-W., Chang, Y.-C., Chan, Y.-C., Hu, S.-H., Liu, M.-Y., & Chang, S.-J. (2020) · Biogerontology · doi:10.1007/s10522-020-09867-x · Cited by 60
Dallaway, A., Kite, C., Griffen, C., Duncan, M. J., Tallis, J. A., Renshaw, D. W., & Hattersley, J. G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110856 · Cited by 63
Meereis-Lemos, E. C. W., Guadagnin, E. C., & Mota, C. B. (2020) · Brazilian Journal of Kinanthropometry and Human Performance · doi:10.1590/1980-0037.2020v22e6070 · Cited by 61
Dodds, R. M., Murray, J. C., Granic, A., Hurst, C., Uwimpuhwe, G., Richardson, S. J., Brayne, C., Matthews, F. E., Sayer, A. A., & CFAS, M. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12660 · Cited by 61
Self-citationVerstraeten, L. M. G., van Wijngaarden, J. P., Pacifico, J., Reijnierse, E. M., Meskers, C. G. M., & Maier, A. B. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.007 · Cited by 64
Evans, K., Abdelhafiz, D., & Abdelhafiz, A. H. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.1942934 · Cited by 59
Benz, E., Wijnant, S. R. A., Trajanoska, K., Arinze, J. T., de Roos, E. W., de Ridder, M. A. J., Williams, R. D., van Rooij, F. J. A., Verhamme, K. M. C., Ikram, M. A., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00628-2021 · Cited by 61
Ageing and exercise‐induced motor unit remodelling
Jones, E. J., Chiou, S., Atherton, P. J., Phillips, B. E., & Piasecki, M. (2022) · The Journal of Physiology · doi:10.1113/jp281726 · Cited by 62
Mirzai, S., Eck, B., Chen, P., Estep, J. D., & Tang, W. H. W. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.009322 · Cited by 66
Assessment of fatigue and its impact in chronic liver disease
Younossi, Z. M., Kremer, A. E., Swain, M. G., Jones, D. E., Bowlus, C. L., Trauner, M., Henry, L. L., & Gerber, L. H. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.008 · Cited by 62
Skeletal muscle and MASLD: Mechanistic and clinical insights
Marjot, T., Armstrong, M. J., & Stine, J. G. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000711 · Cited by 76
“[119] 121] In addition, the European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) have set out a structured procedure for the diagnosis of sarcopenic obesity (Figure 1).”
Therapeutic approaches to osteosarcopenia: insights for the clinician
Fatima, M., Brennan-Olsen, S. L., & Duque, G. (2019) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x19867009 · Cited by 84
Richards, S. J. G., Senadeera, S. C., & Frizelle, F. (2020) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001633 · Cited by 61
Metadata
- Authors
- Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), A. T. E. G. F. E., Bautmans, I., Baeyens, J.-P., Cesari, M., Cherubini, A., Kanis, J., Maggio, M., Martin, F., Michel, J.-P., Pitkala, K., Reginster, J.-Y., Rizzoli, R., Sánchez-Rodríguez, D., & Schols, J.
- Affiliations
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Istanbul University (TR)
- Heidelberg University (DE)
- Research Department, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France
- University of Liège (BE)
- Uppsala University (SE)
- University of Oxford (GB)
- Università Cattolica del Sacro Cuore (IT)
- Université de Toulouse (FR)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Université Côte d'Azur (FR)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Department of Geriatrics, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic
- University of Antwerp (BE)
- Amsterdam Public Health (NL)
- University of Verona (IT)
- University of Geneva (CH)
- Vrije Universiteit Brussel (BE)
- University of Luxembourg (LU)
- University of Milan (IT)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
- University of Parma (IT)
- Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Central Hospital, Unit of Primary Health Care; Helsinki, Finland
- Geriatrics Department, Parc Salut Mar. Rehabilitation Research Group, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM). Universitat Autònoma de Barcelona, Universitat Pompeu Fabra; Barcelona, Spain
- Maastricht University (NL)
- Corresponding author
- Cruz-Jentoft, Alfonso J
- ORCID
- Cruz-Jentoft, Alfonso J
- Bahat, Gülistan
- Bauer, Jürgen
- Bruyère, Olivier
- Cederholm, Tommy
- Cooper, Cyrus
- Landi, Francesco
- Rolland, Yves
- Sayer, Avan Aihie
- Schneider, Stéphane M
- Sieber, Cornel C
- Vandewoude, Maurits
- Visser, Marjolein
- Zamboni, Mauro
- Bautmans, Ivan
- Baeyens, Jean-Pierre
- Cesari, Matteo
- Cherubini, Antonio
- Kanis, John
- Maggio, Marcello
- Martin, Finbarr
- Michel, Jean-Pierre
- Reginster, Jean-Yves
- Rizzoli, René
- Schols, Jos
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-09-24
- Volume
- 48
- Issue
- 1
- Pages
- 16-31
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC6322506
- OpenAlex
- W2897513125
- Semantic Scholar
- ccbd36e412f2f03b0db9d7628ea646fb57c093c9
- Cited by
- 13,818
- References
- 156
- Citations by year
- 2026: 1514 · 2025: 2382 · 2024: 2262 · 2023: 2122 · 2022: 1909 · 2021: 1759 · 2020: 1234 · 2019: 580 · 2018: 25
- FWCI
- 616.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Age and Ageing (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- VU Research Portal (publishedVersion, other-oa)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, cc-by-nc)
- Työväentutkimus Vuosikirja (submittedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Lirias (submittedVersion)
- ORBi (University of Liège) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Funders
- European Working Group on Sarcopenia in Older People 2
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- sarcopenia, sarcopenia definitions, sarcopenia diagnosis, muscle weakness, muscle mass, muscle quality, physical performance, sarcopenia severity, case-finding algorithms, cut-off values, older adults, EWGSOP2 criteria
- MeSH terms
- Europe, Humans, Biomarkers, Muscle, Skeletal, Biomedical Research, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
